source
- TCGX launches $600 million Asia-focused biotech fund to back life-science companies in China and the regionTCGX, a biotech investment firm led by Chen Yu and Dandan Dong, announced a new $600 million fund aimed at the Asian market. The fund will make direct investments in life-science companies located…
- ARPA-H launches Surpass program to speed and broaden clinical trialsThe U.S. Department of Health and Human Services announced a new initiative called Surpass, aimed at removing obstacles that slow clinical development and changing how trials are designed and run.…